Lakefront Biotherapeutics (LKFT) Change in Inventory (2016 - 2020)
Lakefront Biotherapeutics (LKFT) reported Change in Inventory of -$68444.2 for Q1 2020, down 3110.84% year-over-year from $2273.3 in Q2 2019, and down 168.85% quarter-over-quarter from -$25458.4 in Q4 2019.
Lakefront Biotherapeutics (LKFT) Change in Inventory (2016 - 2020) Analysis & Trends
Lakefront Biotherapeutics (LKFT) has 5 years of Change in Inventory data on file, last reported at -$68444.2 in Q1 2020.
- Change in Inventory for Q1 2020 came in at -$68444.2, down 3110.84% year-over-year; the trailing twelve-month figure through Mar 2020 was -$93912.2 (down 690.67% YoY), and the FY2025 annual result was $33.6 million, up 36.41% from the prior year.
- Change in Inventory fell to -$68444.2 in Q1 2020 per LKFT's latest filing, from -$25458.4 in the prior quarter.
- Over five years, Change in Inventory peaked at $31029.6 in Q2 2018 and troughed at -$68444.2 in Q1 2020.
- A 5-year average of -$9292.3 and a median of -$15120.7 in 2018 frame the typical range for Change in Inventory.
- The sharpest annual moves came in 2018 and 2020: Change in Inventory soared 370.34% in 2018, then tumbled 3110.84% in 2020.
- A 5-year view of Change in Inventory shows it stood at $29376.8 in 2016, then tumbled by 196.19% to -$28258.4 in 2017, then jumped by 91.92% to -$2282.8 in 2018, then plunged by 1015.23% to -$25458.4 in 2019, then slumped by 168.85% to -$68444.2 in 2020.
- Business Quant data shows LKFT's Change in Inventory at -$68444.2 in Q1 2020, -$25458.4 in Q4 2019, and $2273.3 in Q1 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 51,468.00 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 97.70 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Lakefront Biotherapeutics | 9.64 Bn | 9.64 Bn | 1.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | -68,444.22 |
| Mar 31, 2020 | -68,444.22 |
| Dec 31, 2019 | -25,458.42 |
| Dec 31, 2019 | -25,458.42 |
| Mar 31, 2019 | 2,273.26 |
| Mar 31, 2019 | 2,273.26 |
| Dec 31, 2018 | -2,282.79 |
| Dec 31, 2018 | -2,282.79 |
| Sep 30, 2018 | -15,120.68 |
| Sep 30, 2018 | -15,120.68 |
| Jun 30, 2018 | 31,029.55 |
| Jun 30, 2018 | 31,029.55 |
| Mar 31, 2018 | -17,199.46 |
| Mar 31, 2018 | -17,199.46 |
| Dec 31, 2017 | -28,258.38 |
| Dec 31, 2017 | -28,258.38 |
| Sep 30, 2017 | 17,625.95 |
| Sep 30, 2017 | 17,625.95 |
| Jun 30, 2017 | 6,597.30 |
| Jun 30, 2017 | 6,597.30 |